ISSN 1662-4009 (online)

ESPE Yearbook of Paediatric Endocrinology (2018) 15 10.23 | DOI: 10.1530/ey.15.10.23

ESPEYB15 10 Type 1 Diabetes Mellitus Therapy and interventions (3 abstracts)

10.23 Effect of financial incentives on glucose monitoring adherence and glycemic control among adolescents and young adults with T1DM: a randomized clinical trial

Wong CA , Miller VA , Murphy K , Small D , Ford CA , Willi SM , Feingold J , Morris A , Ha YP , Zhu J , Wang W & Patel MS


Department of Pediatrics, Duke Clinical Research Institute, Duke-Margolis Center for Health Policy, Duke University, Durham, North Carolina, USA


To read the full abstract: JAMA Pediatr. 2017;171:1176-1183

Adolescence is certainly the most difficult age for reaching T1DM treatment and HbA1c goals. In this age group, most patients have deteriorated metabolic control, and higher risk for acute complications, such as severe hypoglycemia and DKA. Getting into therapeutic contact is very hard in this period of life for diabetes teams and parents. Several concepts to improve this situation have been tested with different, mostly frustrating results. Financial incentives is a plausible idea to improve therapeutic adherence and metabolic control. Here, this trial showed that an incentive of US $60 for a 3-month period of blood glucose testing 4 times a day improved the glucose monitoring goals during the reward period, but did not persist beyond that, and failed to improve HbA1c. Although adolescents are very accessible for incentives in a psychological context, monetary incentives are controversial as not all human behavior is related to monetary incentives after all. Social incentives like family activities could be more effective, but are not easy to put into a trial context. Intrinsic motivation however would be most desirable in diabetes management because it has a long lasting effect.

Article tools

My recent searches

No recent searches.